Dementia is Well-Entrenched in Many Countries, But Saudi Arabia is in a Unique Position to Tackle It

It is the modern epidemic claiming a new victim every three seconds. Fifty million people in the world have the disease now, and that number is forecast to double over the next 20 years, and every 20 years thereafter.

The disease is dementia and it respects no one, disregarding wealth, education and social status. And there is no known cure. But Saudi Arabia is in a unique position to tackle the illness.

In much of the developed world, nearly 18 percent of the population is aged 65 and over. Dementia, in all its variations, is already well-entrenched. But in Saudi Arabia, over-65s make up only 3.3 percent of the population, meaning the Kingdom has time to plan for an issue that is only going to grow.

This year, the cost of dementia treatment and care worldwide tipped from the multibillion into the trillion-dollar bracket. If global dementia were a country, it would be the world’s 18th-largest economy. The emotional cost to the families of sufferers, not to mention the sufferers themselves, is incalculable. Yet in the Middle East, the disease remains largely unacknowledged, leading to little or no care provision and poor documentation.

“People don’t see it as a disease. They think it is simply part of getting old. Awareness is low and stigma is high,” said Paola Barbaroni, CEO of Alzheimer’s Disease International (ADI), a federation of 90 associations. Among them is the Saudi Alzheimer’s Disease Association, which joined in 2017.

The situation is no better in neighboring Gulf countries, she said, adding that the UAE has “very little awareness.” This conclusion is backed by the findings of Dr. Mohammed El-Noaman, a senior geriatrician with the Dubai Health Authority. In his research, he cited “uncertainty” over how to distinguish normal aging from dementia.

El-Noaman found that 16.2 percent of Emiratis had symptoms indicating Alzheimer’s. Yet only 3 percent appear in medical records as Alzheimer’s cases. The fact that dementia remains incurable has bred “prejudice” against spending time or money on diagnosis, he said.

Kuwait has no organization at all to address the illness. More than 2.3 million people in the Middle East and North Africa are living with dementia, but with unreliable data, all figures are estimates.

A study in 2015 found that in the region, only Egypt and Turkey had made concerted efforts to establish the prevalence of the disease, said Barbaroni.

This may be changing. A study last year by the Saudi Alzheimer’s Disease Association found that 130,000 people in the Kingdom were suffering from the condition.

ADI offers an action plan as a blueprint for countries to record, monitor and help those with dementia. But “there is a real problem with the Middle East. All that area is practically devoid of any action,” said Barbaroni. “Documentation of the prevalence of dementia is very poor. We suspect the numbers are widely underestimated.”

Saudi Arabia was one of five countries that were studied for a Readiness Index published in July this year by ADI and the Global Coalition on Aging. The index rated the countries — the others were Argentina, Brazil, India and China — in several categories relating to dementia, including education, care standards and funding. Although the Kingdom scored well on funding (8.33 out of 10) and care standards (7.78), it scored only 2.86 for “strategy and commitment,” ending up with an overall score of 5.9 out of 10. Saudi Arabia also scored poorly in the crucial category of early detection and diagnosis, achieving 6.46 out of 10.

One reason for this is that despite having some of the best hospitals in the Middle East, there is no centralized databank of patient information, including diagnoses. Each hospital operates as an independent entity with no system for sharing information.

The Readiness Index says: “Low awareness of dementia among health-care providers and the general public delays detection, diagnosis and treatment … Due to distrust, lack of information and under-diagnosis, people with dementia are not effectively recruited into clinical trials.”

Saudi Arabia is severely lacking in specialists in geriatric medicine, and there is too little collaboration between geriatrics, psychiatry and neurology — three key disciplines in diagnosing and treating dementia.

“One of the biggest problems is that people have to go to a general practitioner, who isn’t a specialist and hasn’t been trained in dementia,” said Barbaroni.

The shortfall is storing up trouble for the future, according to Dr. Mohammed Basheikh, associate professor and geriatrician at King Abdulaziz University and one of the few specializing in treatment of the elderly.

“There are only 18 geriatric consultants in Saudi Arabia today,” he said. “We’re projected to reach 6 million elderly people in 2030. There is no way that 18 specialists will be able to provide care for all of them.”

However, the Readiness Index deems Saudi Arabia “exceptional” in state provision of care for sufferers and support for their families.

The Health Ministry, via the Saudi Alzheimer’s Disease Association, pays for live-in carers and weekly visits by doctors, nurses, psychologists and therapists, and also covers transport costs and medication. The association holds workshops and runs online training courses for carers and year-round awareness campaigns on TV, radio and social media.

“We believe social awareness is a base, if not the base, to raising the level of care of patients in the future,” an association spokesman told Arab News. It has recruited more than 4,800 volunteers around the country since 2009.

Patients with no family can live in one of the association’s residential facilities. Admirable as all of this is, the association currently has only 1,400-1,500 people in its care. The rest must fend for themselves, relying on family (if they have any) or hiring carers (if they can afford it) who are likely to have no training specific to dementia or even to general care of the elderly.

The private sector would be the obvious candidate to build much-needed residential care facilities. But Saudi regulations require all such facilities to be equipped like a hospital, with a fully functioning emergency department, radiology department and intensive care unit — a huge outlay that is unlikely to encourage private developers to build extended care homes for the elderly.

When it comes to dementia, the West is playing a desperate game of catch-up.

“The Gulf nations, on the other hand, are in a position to learn from earlier mistakes, and they have both the luxury of a little time and the financial capability to plan for this and get it right,” said Barbaroni.

Source: Arab News

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.